Dr Fuchter is a Reader in Chemistry, Director of Postgraduate Studies, and co-Director of the MRes in Drug Discovery in the Department of Chemistry, Imperial College London. He is also a member of the Organic Division Council of the Royal Society of Chemistry and an Associate Editor of the RSC journal MedChemComm. He is involved in multiple multidisciplinary centres of excellence at Imperial including the Institute of Chemical Biology, the Imperial College Network of Excellence in Malaria, the Cancer Research Centre of Excellence, the Antimicrobial Research Collaborative, the Centre for Plastic Electronics and the London Centre for Nanotechnology.
See his research group website.
Dr Matthew Fuchter obtained his first class honours degree (MSci in Chemistry) from the University of Bristol in 2002, where he was awarded the Richard N. Dixon prize as well as an undergraduate Scholarship and several faculty commendations.
In January 2006 he completed his PhD research entitled “Synthetic Studies on Porphyrazines: Biological Applications and New Preparative Methods” under the supervision of Professor Anthony G. M. Barrett, FRS FMedSci (Imperial College London, UK) and in close collaboration with Prof. Brian Hoffman (Northwestern University, USA). Following a short spell as a Research Associate at Imperial College, Dr Fuchter was appointed as a CSIRO Research Fellow at the Commonwealth Scientific and Industrial Research Organisation, Australia as well as a Visiting Fellow at the University of Melbourne, where he worked with Professor Andrew B Holmes, FRS.
He briefly took up an independent Fellowship position in 2007 at the School of Pharmacy (University of London), before being appointed as a Lecturer in Synthetic and Medicinal Chemistry at Imperial College London in July 2008. He was subsequently promoted to Senior Lecturer in July 2012, and Reader in late 2015. In 2014 he was awarded the Royal Society of Chemistry's Harrison-Meldola Memorial Prize, as well as being admitted to the Royal Society of Chemistry as a Fellow. In 2015, he was selected as a Thieme Chemistry Journal Awardee by the Editorial Board for the Thieme Chemistry journals and received a Diploma for being the 'most meritorious runner-up' of the European Federation for Medicinal Chemistry (EFMC) Prize for a Young Medicinal Chemist in Academia (2015). In 2017, he won an Imperial College President’s Excellence in Research Award and a President’s Medal (together with Professors Tony Barrett, Charles Coombes and Simak Ali) for Excellence in Innovation and Entrepreneurship. He was recently awarded the prestigious 2018 Tetrahedron Young Investigator Award for Bioorganic and Medicinal Chemistry and a 5-year EPSRC Established Career Fellowship.
Fuchter MJ, 2018, Editorial, Bioorganic & Medicinal Chemistry, Vol:26, ISSN:0968-0896, Pages:2919-2920
et al., 2018, Correction to Emergent Properties of an Organic Semiconductor Driven by its Molecular Chirality., Acs Nano
et al., 2018, Correction: A computational exploration of the crystal energy and charge-carrier mobility landscapes of the chiral helicene molecule., Nanoscale, Vol:10
et al., 2018, ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment, UK Breast Cancer Research Symposium, AMER ASSOC CANCER RESEARCH, Pages:1156-1166, ISSN:1535-7163
et al., Processes for preparing 5,7-diaminopyrazolo[1,5-.alpha.]pyrimidine derivatives via regioselective aminations of dichloro(pyrazolo)pyrimidines with primary and secondary amines., WO 2010068838